Very high institutional ownership
Over 100% institutionally held. Three biggest holders are Fidelity, Wellington and Morgan Stanley who own a combined 36% of IRWD. Next few quarters we will be seeing revenues ramp up as linaclotide sales begin with profitability expected in late 2013